CNS Pharmaceuticals, Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CNS Pharmaceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2019-09-30 was $56.25K.
- CNS Pharmaceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2019-06-30 was $49.18K.
- CNS Pharmaceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2018-03-31 was $7.50K.
- CNS Pharmaceuticals, Inc. stock issued during period, value, issued for services for fiscal 2019 was $150.00K, a 1900.00% increase from fiscal 2018.
- CNS Pharmaceuticals, Inc. stock issued during period, value, issued for services for fiscal 2018 was $7.50K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2019-12-31 | $150.00K 10-K · filed 2021-02-12 | |
| 2019-09-30 | $56.25K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $49.18K 10-Q · filed 2020-11-12 | |
| 2018-12-31 | $7.50K 10-K · filed 2020-03-12 | |
| 2018-03-31 | $7.50K 10-Q · filed 2019-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |